The Petri Dish: Fulcrum CEO steps down; Moderna cools on mpox vaccine


ModernaCEO Stephane Bancel doesn't see much of a market for the company's mRNA-based vaccine for mpox (formerly called "monkeypox") despite "fantastic" preclinical data.

Previous 2023 Faces to Watch: Syneos Health CEO Michelle Keefe
Next Stories to Watch in 2023: Is this the year we'll see vertical progress on the Downtown Greensboro Westin Hotel?